if they are confirmed by long term studies , these results would suggest that acebutolol is safer to use than non-cardioselective beta-blockers in the treatment of coronary insufficiency and of hypertension in diabetics exposed to the risk of hypoglycaemia .
C0000946
acebutolol
C0020538
hypertension